Therapeuticsmd, Inc. · NASDAQ:TXMD
Baselake Partners, LP reported a 5.20% stake in Therapeuticsmd, Inc. (Schedule 13G)
Event Mar 30, 2026 · Filed Apr 6, 2026
Baselake Partners, LP reported a 5.20% stake in Therapeuticsmd, Inc., 607,181 shares, as a passive investor on Mar 30, 2026. Filed Apr 6, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 607,181
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baselake Partners, LP | 5.20% | 607,181 |
| Baselake Management, LLC | 5.20% | 607,181 |
| David Paolella | 5.20% | 607,181 |